2-Chloro-3-nitro-5-(trifluoromethyl)pyridine

Catalog No. :
ACFCUM841
CAS No. :
72587-15-6
Molecular Formula :
C6H2ClF3N2O2
Molecular Weight :
226.54

IUPAC Name:2-chloro-3-nitro-5-(trifluoromethyl)pyridine

2-Chloro-3-nitro-5-(trifluoromethyl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10g97%$53.00Login to see priceIn stockIn stock
25g97%$65.00Login to see priceIn stockIn stock
100g97%$258.00Login to see priceIn stockIn stock
500g97%$1251.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-3-nitro-5-(trifluoromethyl)pyridine
IUPAC Name2-chloro-3-nitro-5-(trifluoromethyl)pyridine
MDL No.MFCD06255171
Molecular FormulaC6H2ClF3N2O2
Molecular Weight226.54
SMILESClC1=NC=C(C=C1[N+](=O)[O-])C(F)(F)F
InChI KeyDRPIKFKCAJGTJF-UHFFFAOYSA-N
Synonym2-chloro-3-nitro-5-trifluoromethyl pyridine | 2-CHLORO-5-(TRIFLUOROMETHYL)-3-NITROPYRIDINE | SCHEMBL572669 | MFCD06255171 | CS-10667 | AM62429 | AB23715 | A837569 | FT-0654113 | Pyridine, 2-chloro-3-nitro-5-(trifluoromethyl)- | SY017800 | J-508794 | AKOS0
CAS No.72587-15-6
PubChem CID4736950

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACFCUM841 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACCUJM091 route compound structure diagram
    ACCUJM0911851650-55-9 In Stock
  4. Then
  5. ACFCUM841 route product structure diagram
    ACFCUM84172587-15-6 In Stock
Inquiry

2. ACFCUM841 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCUJM091 route compound structure diagram
    ACCUJM0911851650-55-9 In Stock
  2. Then
  3. ACFCUM841 route product structure diagram
    ACFCUM84172587-15-6 In Stock
Inquiry

Comments (0)